ACU vs MCK vs SKYA Stock Comparison

Acme United, Mckesson and SkyAI Prices as of Oct 27, 2026 Peers: Industry group
ACU Acme United Corp
$65.77 +4.8% 1M +68.8% 1Y
Market cap
$254.41M
P/E
24.8x
Revenue (TTM)
—
Div. yield
–
Medical Supplies Healthcare
4 wins
MCK Mckesson Corp
$967.03 +11.6% 1M +19.2% 1Y
Market cap
$113.87B
P/E
24.8x
Revenue (TTM)
$410.98B
Div. yield
0.00%
Drug Distribution Healthcare
3 wins
SKYA SkyAI, Inc.
$2.91 +54.8% 1M -46.2% 1Y
Market cap
$212.31M
P/E
–
Revenue (TTM)
$194.22K
Div. yield
–
Medical Supplies Healthcare
2 wins

Head to Head

9 decided of 12

Acme United leads on 4 of the 12 questions below (Acme United 4, Mckesson 3, SkyAI 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionACUMCKSKYALeader
Larger companyMarket capitalisation $254.41M $113.87B $212.31M MCK
Cheaper on earningsLower P/E, profitable companies only 24.8x 24.8x -0.7x ACU
Cheaper on forward earningsLower price / next fiscal year consensus EPS 23.9x 20.5x 0.0x SKYA
Faster revenue growthRevenue growth, trailing twelve months — +8.8% +108.9% SKYA
More profitableNet margin, trailing twelve months — 1.1% -158,431.4% MCK
Better return on capitalReturn on invested capital — 107.9% — –
Less leveragedLower net debt / EBITDA — 0.6x — –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +68.8% +19.2% -46.2% ACU
Better 5-year returnAnnualised price return, 5 years +12.8%/yr +36.4%/yr — MCK
Less volatileAnnualised volatility, 1 year 30.7% 30.7% 106.0% ACU
Higher overall scoreMean of the five percentile scores vs peers 71/100 57/100 26/100 ACU

Percentile Scorecard

ACUMCKSKYA

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisACUMCKSKYA
Valuation 88 #28 of 227 50 #13 of 25 2 #222 of 227
Growth – 65 #9 of 24 6 #205 of 219
Profitability – 61 #10 of 24 1 #204 of 206
Financial Health 60 #97 of 238 52 #13 of 26 95 #14 of 238
Shareholder Returns 65 #48 of 134 57 #7 of 15 –
Overall 71 57 26
  • ACU ranked among 247 companies in Medical Devices and Diagnostics
  • MCK ranked among 27 companies in Healthcare Payers and Distributors
  • SKYA ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodACUMCKSKYASPY
1 month +4.8%+11.6%+54.8% -0.2%
3 months +10.5%+8.7%+107.9% +3.9%
6 months +57.9%+15.8%+62.6% +8.2%
Year to date +63.2%+17.9%+43.3% +12.9%
1 year +68.8%+19.2%-46.2% +12.3%
3 years +116.3%+115.8%-99.9% +87.4%
3 years, per year +29.4%+29.3%-90.1% +23.3%
5 years +82.7%+371.7%— +67.9%
5 years, per year +12.8%+36.4%— +10.9%
10 years +215.0%+502.5%— +261.1%
10 years, per year +12.2%+19.7%— +13.7%

Risk

MeasureACUMCKSKYASPY
Volatility, 1Y 30.7%30.7%106.0% 12.7%
Downside volatility, 1Y 24.2%27.4%104.5% 12.7%
Beta vs S&P 500, 1Y 0.23-0.272.59 1.00
Return / volatility, 1Y 2.240.62-0.44 0.97
Max drawdown, 5Y -43.5%-27.2%-100.0% -25.4%
From 52-week high 0.0%-6.1%-46.2% -1.2%
52-week high $65.77$1,030.18$5.41 $779.14
52-week low $35.50$725.17$0.95 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleACUMCKSKYA
P/E now vs peer median 24.8xmedian 29.6x 25.0xmedian 23.9x -0.7xmedian 29.6x
P/S now vs peer median 1.2xmedian 2.9x 0.3xmedian 0.3x 1,080xmedian 2.9x
EV/EBITDA now vs peer median —median 17.4x 16.2xmedian 13.4x —median 17.4x
P/FCF now vs peer median 15.8xmedian 22.3x 17.6xmedian 15.5x —median 22.3x
P/B now vs peer median 2.0xmedian 2.3x -26.6xmedian 2.5x 1.3xmedian 2.3x
PEG now vs peer median —median 1.04 2.09median 1.34 0.01median 1.04

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsACUMCKSKYA
Revenue – $410.98B $194.22K
Gross profit – $14.96B $321.93K
Operating income – $6.50B -$289.52M
Net income – $5.30B -$307.71M
Free cash flow – $6.42B –
R&D – – $399.91K
EPS (diluted) – $38.52 $-4.27
Cash & equivalents $7.94M $5.16B $12.07M
Total debt – $9.73B –
Shares (diluted) 4.14M 119.20M 72.09M
Enterprise value $254.41M $97.77B $171.02M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricACUMCKSKYA
P/E 24.8x 25.0x -0.7x
P/FCF 15.8x 17.6x –
P/Operating cash flow – 16.5x –
P/S 1.2x 0.3x 1,080x
P/B 2.0x -26.6x 1.3x
P/Tangible book 2.7x -13.7x 16.1x
EV/EBITDA – 16.2x –
EV/EBIT – 18.1x -0.7x
EV/Revenue – 0.3x 1,018x
EV/FCF – 18.3x –
EV/Operating cash flow – 17.1x –
PEG (3Y EPS CAGR) – 2.09 0.01

Growth

14 metrics
MetricACUMCKSKYA
Revenue growth (1Y) – 8.8% 108.9%
Revenue CAGR (3Y) – 13.1% 23.8%
Gross profit growth (1Y) – 11.2% –
Gross profit CAGR (3Y) – 6.6% –
Operating income growth (1Y) – 46.6% -5,525%
Operating income CAGR (3Y) – 13.5% -212.8%
Net income growth (1Y) – 58.1% -42,440%
Net income CAGR (3Y) – 10.7% -238.0%
EPS growth (1Y) – 52.8% -487.2%
EPS CAGR (3Y) – 12.0% -84.2%
Operating cash flow growth (1Y) – 4.7% –
Operating cash flow CAGR (3Y) – 10.7% –
Free cash flow growth (1Y) – 6.8% –
Free cash flow CAGR (3Y) – 11.3% –

Profitability

14 metrics
MetricACUMCKSKYA
Gross margin – 3.6% 165.8%
EBITDA margin – 1.8% –
Operating margin – 1.6% -149,065%
Pretax margin – 1.6% -151,352%
Net margin – 1.1% -158,431%
FCF margin – 1.6% –
Operating cash flow margin – 1.7% –
Return on equity – – -140.2%
Return on assets – 6.2% -137.6%
Return on invested capital – 107.9% –
Return on capital employed – 43.4% -136.7%
Asset turnover – 4.8x 0.0x
Cash conversion (OCF / net income) – 1.3x –
Stock comp / revenue – – 48,037%

Financial Health

11 metrics
MetricACUMCKSKYA
Debt / assets – 11.0% –
Debt / equity – -2.3x –
Net debt / EBITDA – 0.6x –
Debt / FCF – 1.5x –
Liabilities / assets 39.9% 104.8% 1.9%
Equity / assets 60.1% -4.8% 98.1%
Interest coverage – 23.6x –
Current ratio 3.9x 0.9x 5.3x
Quick ratio – 0.5x 4.4x
Cash ratio – 0.1x 4.2x
Altman Z-score – 5.89 31.41

Shareholder Returns

7 metrics
MetricACUMCKSKYA
Dividend yield 1.0% 0.4% –
Net buyback yield – 5.9% –
Shareholder yield 1.0% 6.2% –
Payout ratio (earnings) – 7.4% –
Payout ratio (FCF) – 6.1% –
Dividend growth (1Y) – 11.3% –
Dividend CAGR (3Y) – 10.0% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusACUMCKSKYA
Forward P/E 23.9xFY2026 20.5xFY2026 0.0xFY2026
EPS, next fiscal year $2.75FY2026 $47.15FY2026 $2,362.06FY2026
EPS growth, next FY +10.4%FY2026 +20.6%FY2026 –
EPS growth, the year after +4.0% +11.0% –
Revenue, next fiscal year $217.65MFY2026 $444.47BFY2026 $70.01MFY2026
Revenue growth, next FY +10.7%FY2026 +10.2%FY2026 +34,200.1%FY2026
Revenue growth, the year after +0.7% +1.5% +17.5%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersACUMCKSKYA
Held by institutions 73.5% 89.1% –
Institutions holding 84 2,009 –
Change in shares held, QoQ +1.3% -0.7% –
Institutions buying 47 881 –
Institutions selling 21 791 –
Buyers to sellers 2.24 1.11 –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ACUMCKSKYA
ACU 1.00 0.10 0.00
MCK 0.10 1.00 -0.11
SKYA 0.00 -0.11 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ACU, MCK and SKYA?

Mckesson (MCK) is the largest by market capitalisation: Acme United (ACU) $254.41M, Mckesson (MCK) $113.87B, SkyAI (SKYA) $212.31M.

Which stock is cheaper, ACU, MCK and SKYA?

Acme United (ACU) trades on the lowest price-to-earnings ratio (Acme United (ACU) 24.8x, Mckesson (MCK) 24.8x, SkyAI (SKYA) -0.7x). On next year's consensus earnings, SkyAI (SKYA) is cheapest (Acme United (ACU) 23.9x, Mckesson (MCK) 20.5x, SkyAI (SKYA) 0.0x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

SkyAI (SKYA) grew revenue fastest over the trailing twelve months: Mckesson (MCK) +8.8%, SkyAI (SKYA) +108.9%.

Which company is more profitable?

Mckesson (MCK) has the highest net margin (Mckesson (MCK) 1.1%, SkyAI (SKYA) -158,431.4%).

Which stock has performed better?

Over the past year Acme United (ACU) returned the most: Acme United (ACU) +68.8%, Mckesson (MCK) +19.2%, SkyAI (SKYA) -46.2%. Over five years, Mckesson (MCK) compounded fastest (Acme United (ACU) +12.8%/yr, Mckesson (MCK) +36.4%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Acme United (ACU) 0.00%, Mckesson (MCK) 0.00%, SkyAI (SKYA) 0.00%. Acme United (ACU) and SkyAI (SKYA) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Acme United (ACU) has been the steadiest (Acme United (ACU) 30.7%, Mckesson (MCK) 30.7%, SkyAI (SKYA) 106.0%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ACU, MCK and SKYA?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Acme United (ACU) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.